SCHEMBL1680739

SCHEMBL1680739

NC(=O)c1ccc(Cc2ccc(Oc3ccccc3Cl)s2)nc1N

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR52 Q9Y2T5 1/20 0.34
IDO1 P14902 1/20 0.34
CXCL8 P10145 1/20 0.33
RAB9A P51151 2/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
NPC1 O15118 1/20 0.33
IKBKB O14920 2/20 0.32
MAP4K4 O95819 1/20 0.32
MAPT P10636 2/20 0.32
TP53 P04637 1/20 0.32
RXFP1 Q9HBX9 1/20 0.32
KMT2A Q03164 1/20 0.32
ATM Q13315 1/20 0.32
SLC2A1 P11166 1/20 0.31
HTT P42858 2/20 0.31
CTNNB1 P35222 1/20 0.31
CDC7 O00311 1/20 0.31
PIN1 Q13526 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1680736 0.76 CXCL8 (0.35) IDO1CXCL8RAB9AKDM4ENPC1
SCHEMBL1680855 0.69 DPP4 (0.42) IDO1CXCL8ALDH1A1LMNAHTT
SCHEMBL1680737 0.69 ALDH1A1 (0.46) RAB9AALDH1A1LMNANPC1KMT2A
SCHEMBL4978178 0.65 ADRA1D (0.44) LMNAIKBKB
SCHEMBL12808365 0.64 MAPT (0.39) CXCL8RAB9AALDH1A1LMNANPC1
SCHEMBL14917467 0.62 PARP1 (0.57) KDM4EALDH1A1IKBKBCDC7
SCHEMBL1680407 0.62 MAPK8 (0.40) KDM4EALDH1A1LMNAMAPTTP53
SCHEMBL1734145 0.61 NNMT (0.42) KDM4EALDH1A1LMNAIKBKBATM
SCHEMBL7709590 0.60 CTNNB1 (0.51) RAB9AKDM4EALDH1A1LMNANPC1
SCHEMBL392559 0.59 IKBKB (0.46) IDO1KDM4EALDH1A1LMNAIKBKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110195999-A1 NOVEL ANTIFUNGAL AGENT CONTAINING HETEROCYCLIC COMPOUND NAKAMOTO KAZUTAKA 2011-08-11 US disclosed
US-7932272-B2 Antifungal agent containing heterocyclic compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2011-04-26 US disclosed
US-20090227799-A1 Novel Antimalarial Agent Containing Heterocyclic Compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-09-10 US disclosed
US-20070105943-A1 Novel antifungal agent containing heterocyclic compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2007-05-10 US disclosed
EP-1782811-A1 NOVEL ANTIMALARIA AGENT CONTAINING HETEROCYCLIC COMPOUND Eisai R&D Management Co., Ltd. (JP) 2007-05-09 EP disclosed
EP-1669348-A1 NOVEL ANTIFUNGAL AGENT COMPRISING HETEROCYCLIC COMPOUND Eisai Co., Ltd. (JP) 2006-06-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110195999-A1 NOVEL ANTIFUNGAL AGENT CONTAINING HETEROCYCLIC COMPOUND ERG28, CYP51A1, XPO1 GPR52 2940/4885IDO1 95/4885CXCL8 780/4885
US-20090227799-A1 Novel Antimalarial Agent Containing Heterocyclic Compound XPO1, THPO, G6PD GPR52 2499/4885IDO1 1124/4885CXCL8 440/4885
US-20070105943-A1 Novel antifungal agent containing heterocyclic compound ERG28, DPM1, CYP51A1 GPR52 3233/4885IDO1 115/4885CXCL8 861/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.